HOMILADORLIKNING 1-TRIMESTRIDA BRONXIAL ASTMANING DA’VO TAKTIKASI
Keywords:
cho‘zilgan o‘tkir bronxit, o‘zgargan bronxlar reaktivligi, virusli infektsiya, tashqi nafas olish funksiyasi.Abstract
Maqolada homiladorlikning 1-trimestrida bronxial astmaning davo taktikasi haqida aytib o‘tilgan. Bronxlar va o‘pkalarda uzoq davom etadigan va takrorlanadigan yallig‘lanish jarayonlarining ko‘p qirrali klinik tavsifi, shuningdek, cho‘zilgan o‘tkir bronxit bilan og‘rigan bemorlarda doimiy virusli infektsiya va bronxial reaktivlikning o‘zgarishi o‘rtasidagi bog‘liqlik keltirilgan.
References
Goldstein L.H., Weber-Schöndorfer C., Berkovitch M. Antiasthmatic and cough medication. In: Drugs During Pregnancy and Lactation (Third Edition) Treatment Options and Risk Assessment. Amsterdam: Academic Press; 2015.
Rudra C.B., Williams M.A., Frederick I.O. et al. Maternal asthma and risk of preeclampsia: a casecontrol study. J. Reprod. Med. 2006; 51: 94—100.
Bakhireva L.N., Schatz M., Jones K.L. et al. Organization of Teratol- ogy Information Specialists Collaborative Research Group: Asthma control during pregnancy and the risk of preterm delivery or impaired fetal growth. Ann. Allergy Asthma Immunol. 2008; 101: 137—43.
Blais L., Kettani F.Z., Forget A. Relationship between maternal asth- ma, its severity and control and abortion. Hum. Reprod. 2013; 28: 908—15.
Breton M.C., Beauchesne M.F., Lemière C. et al. Risk of perinatal mortality associated with asthma during pregnancy. Thorax. 2009; 64: 101—6.
Firoozi F., Lemière C., Ducharme F.M. et al. Effect of maternal mod- erate to severe asthma on perinatal outcomes. Respir. Med. 2010; 104: 1278—87.
Murphy V.E., Wang G., Namazy J.A. et al. The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta- analysis. BJOG. 2013; 120: 812—22.
Aylamazyan E.K., Kulakov V.I., Radzinskiy V.E., Savel'eva G.M., eds. Obstetrics. National Guideline [Akusherstvo. Natsional'noe Ru- kovodstvo]. Moscow: GEOTAR-Media; 2009. (in Russian)
Murphy V.E., Namazy J.A., Powell H. et al. A meta-analysis of ad- verse perinatal outcomes in women with asthma. BJOG. 2011; 118: 1314—23.
Cossette B., Forget A., Beauchesne M.F. et al. Impact of maternal use of asthma-controller therapy on perinatal outcomes. Thorax. 2013; 68: 724—30.
Murphy V.E., Powell H., Wark P.A. et al. A prospective study of re- spiratory viral infection in pregnant women with and without asthma. Chest. 2013; 144: 420—7.
Forbes R.L., Gibson P.G., Murphy V.E. et al. Impaired type I and III interferon response to rhinovirus infection during pregnancy and asthma. Thorax. 2012; 67: 209—14.
Vanders R.L., Gibson P.G., Wark P.A. et al. Alterations in inflamma- tory, antiviral and regulatory cytokine responses in peripheral blood mononuclear cells from pregnant women with asthma. Respirology. 2013; 18: 827—33.
Vasilakis-Scaramozza C., Aschengrau A., Cabral H.J. et al. Asthma drugs and the risk of congenital anomalies. Pharmacotherapy. 2013; 33: 363—8.
Lin S., Munsie J.P., Herdt-Losavio M.L. et al. Maternal asthma medi- cation use and the risk of selected birth defects. Pediatrics. 2012; 129: e317—24.
Tegethoff M., Greene N., Olsen J. et al. Inhaled glucocorticoids dur- ing pregnancy and offspring pediatric diseases: a national cohort study. Am. J. Respir. Crit. Care Med. 2012; 185: 557—63.
Tegethoff M., Olsen J., Schaffner E. et al. Asthma during pregnancy and clinical outcomes in offspring: a national cohort study. Pediat- rics. 2013; 132: 483—91.
Hardy-Fairbanks A.J., Baker E.R. Asthma in pregnancy: pathophysi- ology, diagnosis and management. Obstet. Gynecol. Clin. North Am. 2010; 37 (2): 159—72.
Vatti R.R., Teuber S.S. Asthma and pregnancy. Clin. Rev. Allergy Im- munol. 2012; 43 (1—2): 45—56.
Serov V.N., Sukhikh G.T., eds. Clinical Recommendations, Obstet- rics and Gynecology {Klinicheskie Rekomendatsii. Akusherstvo i Ginekologiya]. Moscow: GEOTAR-Media; 2014. (in Russian)
